 |
7 Diseases |  |
5 Trials |
|
5 Trials |  |
247 News |  |
| «1234 |
- ||||||| Symproic (naldemedine) / Shionogi, Collegium Pharma
Trial completion: Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation (clinicaltrials.gov) - May 9, 2016
P3, N=540, Completed, Sponsor: Shionogi
Active, not recruiting --> Completed
- ||||| Symproic (naldemedine) / Shionogi, Collegium Pharma
Enrollment change, Trial primary completion date: Long Term Safety of Naldemedine (clinicaltrials.gov) - Nov 17, 2015
P3, N=1200, Active, not recruiting, Sponsor: Shionogi
Active, not recruiting --> Completed N=1500 --> 1200 | Trial primary completion date: May 2016 --> Jan 2016
- ||||||| Symproic (naldemedine) / Shionogi, Collegium Pharma
Trial completion, Trial primary completion date: Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation (clinicaltrials.gov) - Nov 17, 2015
P3, N=540, Completed, Sponsor: Shionogi
N=1500 --> 1200 | Trial primary completion date: May 2016 --> Jan 2016 Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Jan 2015
- ||||| Symproic (naldemedine) / Shionogi, Collegium Pharma
Enrollment closed: Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation (clinicaltrials.gov) - Feb 19, 2015
P3, N=540, Active, not recruiting, Sponsor: Shionogi
Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Jan 2015 Recruiting --> Active, not recruiting
- ||||| Symproic (naldemedine) / Shionogi, Collegium Pharma
Enrollment closed: Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation (clinicaltrials.gov) - Feb 19, 2015
P3, N=540, Active, not recruiting, Sponsor: Shionogi
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- ||||| Symproic (naldemedine) / Shionogi, Collegium Pharma
Enrollment closed: Long Term Safety of Naldemedine (clinicaltrials.gov) - Feb 19, 2015
P3, N=1500, Active, not recruiting, Sponsor: Shionogi
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- |||||||||| Symproic (naldemedine) / Shionogi, Collegium Pharma
New P3 trial: Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation (clinicaltrials.gov) - Nov 21, 2013
P3, N=540, Recruiting, Sponsor: Shionogi
- |||||||||| Symproic (naldemedine) / Shionogi, Collegium Pharma
New P3 trial: Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation (clinicaltrials.gov) - Oct 16, 2013
P3, N=540, Recruiting, Sponsor: Shionogi
- |||||||||| Symproic (naldemedine) / Shionogi, Collegium Pharma
New P3 trial: Long Term Safety of Naldemedine (clinicaltrials.gov) - Oct 16, 2013
P3, N=1500, Recruiting, Sponsor: Shionogi
- |||| Symproic (naldemedine) / Shionogi, Collegium Pharma
Trial completion: A Study of Naldemedine (S-297995) for the Treatment of Opioid-Induced Constipation in Adults With Non-Malignant Chronic Pain Receiving Opioid Therapy (clinicaltrials.gov) - Apr 15, 2013
P2, N=244, Completed, Sponsor: Shionogi
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||||| Symproic (naldemedine) / Shionogi, Collegium Pharma
New P2 trial: A Study of Naldemedine (S-297995) for the Treatment of Opioid-Induced Constipation in Adults With Non-Malignant Chronic Pain Receiving Opioid Therapy (clinicaltrials.gov) - Sep 27, 2011
P2, N=244, Completed, Sponsor: Shionogi
- |||| Symproic (naldemedine) / Shionogi, Collegium Pharma
Trial completion: Study to Evaluate the Safety and Efficacy of Naldemedine (S-297995) for the Treatment of Opioid-Induced Bowel Dysfunction in Subjects With Chronic Pain (clinicaltrials.gov) - Sep 12, 2011
P2, N=72, Completed, Sponsor: Shionogi
Active, not recruiting --> Completed Enrolling by invitation --> Completed